Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.

ABSTRACT:

Trial registration

ClinicalTrials.gov NCT03474198, NCT01659437.

SUBMITTER: Converse PJ 

PROVIDER: S-EPMC6107292 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature